BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 25820608)

  • 21. Validity of image-defined risk factors in localized neuroblastoma: A report from two centers in Western Japan.
    Fumino S; Kimura K; Iehara T; Nishimura M; Nakamura S; Souzaki R; Nishie A; Taguchi T; Hosoi H; Tajiri T
    J Pediatr Surg; 2015 Dec; 50(12):2102-6. PubMed ID: 26388125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How well do image-defined risk factors (IDRFs) predict surgical outcomes and survival in patients with neuroblastoma? A systematic review and meta-analysis.
    Parhar D; Joharifard S; Lo AC; Schlosser MP; Daodu OO
    Pediatr Surg Int; 2020 Aug; 36(8):897-907. PubMed ID: 32533235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome prediction by molecular detection of minimal residual disease in bone marrow for advanced neuroblastoma.
    Horibe K; Fukuda M; Miyajima Y; Matsumoto K; Kondo M; Inaba J; Miyashita Y
    Med Pediatr Oncol; 2001 Jan; 36(1):203-4. PubMed ID: 11464885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image-defined risk factors in localized thoracic neuroblastoma and ganglioneuroma.
    Butzer SK; Krug B; Reisberg M; Fuchs J; Warmann SW; Hubertus J; Körber F; Berthold F; Simon T; Hero B
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30605. PubMed ID: 37534915
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between image-defined risk factors and neuroblastoma outcomes.
    Phelps HM; Ndolo JM; Van Arendonk KJ; Chen H; Dietrich HL; Watson KD; Hilmes MA; Chung DH; Lovvorn HN
    J Pediatr Surg; 2019 Jun; 54(6):1184-1191. PubMed ID: 30885556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term results of the combination of the N7 induction chemotherapy and the busulfan-melphalan high dose chemotherapy.
    Valteau-Couanet D; Le Deley MC; Bergeron C; Ducassou S; Michon J; Rubie H; Le Teuff G; Coze C; Plantaz D; Sirvent N; Bouzy J; Chastagner P; Hartmann O
    Pediatr Blood Cancer; 2014 Jun; 61(6):977-81. PubMed ID: 23970413
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.
    Kohler JA; Rubie H; Castel V; Beiske K; Holmes K; Gambini C; Casale F; Munzer C; Erminio G; Parodi S; Navarro S; Marquez C; Peuchmaur M; Cullinane C; Brock P; Valteau-Couanet D; Garaventa A; Haupt R
    Eur J Cancer; 2013 Nov; 49(17):3671-9. PubMed ID: 23907002
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
    Alvarado CS; London WB; Look AT; Brodeur GM; Altmiller DH; Thorner PS; Joshi VV; Rowe ST; Nash MB; Smith EI; Castleberry RP; Cohn SL
    J Pediatr Hematol Oncol; 2000; 22(3):197-205. PubMed ID: 10864050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastoma.
    De Ioris MA; Castellano A; Ilari I; Garganese MC; Natali G; Inserra A; De Vito R; Ravà L; De Pasquale MD; Locatelli F; Donfrancesco A; Jenkner A
    Eur J Cancer; 2011 Mar; 47(4):572-8. PubMed ID: 21112775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.
    Tweddle DA; Pinkerton CR; Lewis IJ; Ellershaw C; Cole M; Pearson AD
    Med Pediatr Oncol; 2001 Jan; 36(1):239-42. PubMed ID: 11464894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bilateral adrenal neuroblastoma in the infant: Is it an image-defined risk factor?
    Marino S; La Spina M; Scuderi MG; Di Benedetto V; Magro G; Belfiore G; Coronella M; D'Amico S; Lo Nigro L; Russo G; Di Cataldo A
    Pediatr Hematol Oncol; 2016 May; 33(4):259-63. PubMed ID: 27285992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of image-defined risk factors with clinical features, tumor biology, and outcomes in neuroblastoma: a single-center retrospective study.
    Yang DD; Liu C; Gao J; Hu QJ; Liang Y; Liu J
    Eur J Pediatr; 2023 May; 182(5):2189-2196. PubMed ID: 36856889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
    Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
    J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excellent outcome with reduced treatment in infants with nonmetastatic and unresectable neuroblastoma without MYCN amplification: results of the prospective INES 99.1.
    Rubie H; De Bernardi B; Gerrard M; Canete A; Ladenstein R; Couturier J; Ambros P; Munzer C; Pearson AD; Garaventa A; Brock P; Castel V; Valteau-Couanet D; Holmes K; Di Cataldo A; Brichard B; Mosseri V; Marquez C; Plantaz D; Boni L; Michon J
    J Clin Oncol; 2011 Feb; 29(4):449-55. PubMed ID: 21172879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implication of Image-Defined Risk Factors for the Extent of Surgical Resection and Clinical Outcome in Patients with Pelvic Neuroblastoma.
    Froeba-Pohl A; von Schweinitz D; Muehling J; Paolini M; Hubertus J
    Eur J Pediatr Surg; 2021 Aug; 31(4):362-366. PubMed ID: 32862422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF; Liu DG; Su YS; Lin TY; Chen XQ; He YJ
    Ai Zheng; 2003 Dec; 22(12):1343-5. PubMed ID: 14693065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Value of surgical resection in children with high-risk neuroblastoma.
    Englum BR; Rialon KL; Speicher PJ; Gulack B; Driscoll TA; Kreissman SG; Rice HE
    Pediatr Blood Cancer; 2015 Sep; 62(9):1529-35. PubMed ID: 25810376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.